Prevail Partners
Overview
Prevail Partners is a venture capital firm that invests in life sciences companies with a focus on therapeutics, devices, and diagnostics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Stamford Pharmaceuticals Inc | Oct 2023 | Series A | Lead |
| SOM Biotech | Nov 2023 | Series B | Co-investor |
| Omnix Medical Ltd. | Oct 2025 | Series C | Co-investor |
| Triple Hair Group Inc. | Jun 2024 | VC Round | Lead |
| PolyPhotonix | Jan 2022 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Prevail Partners based?
Prevail Partners is headquartered in Philadelphia, Pennsylvania, United States.
When was Prevail Partners founded?
Prevail Partners was founded in 2008.
How many portfolio companies does Prevail Partners have?
Prevail Partners has 5 portfolio companies in Caplight's dataset.
What are some companies in Prevail Partners's portfolio?
Portfolio companies visible on Caplight include Stamford Pharmaceuticals Inc, SOM Biotech, Omnix Medical Ltd., Triple Hair Group Inc., PolyPhotonix.
What was Prevail Partners's most recent investment shown here?
Prevail Partners's most recent investment in this portfolio sample was in Omnix Medical Ltd. in 2025.
What sectors does Prevail Partners focus on?
Prevail Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Consumer & Commerce.
What company stages does Prevail Partners focus on?
Stage focus information for Prevail Partners is not publicly available.